The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback